Studies

Active Clinical Trials Recruiting Volunteers

The ACTIV4A Inpatient study is testing if treatments that aim to prevent blood vessel injuries and blood clots improve recovery from patients hospitalized due to COVID-19.

3

The ACTIV4 Host Tissue platform is testing if treatments targeting the host-tissue response to SARS-CoV-2 infection can improve recovery and prevent worsening in patients hospitalized with COVID-19.

20
Closed Clinical Trials

The ACTIV3 study is testing if monoclonal antibody treatments -- laboratory-made proteins that mimic the immune system’s abilities -- improve recovery from patients hospitalized due to COVID-19.

5 https://clinicaltrials.gov/ct2/show/NCT04501978

The ACTIV3b study is testing if treatments improve recovery from patients hospitalized due to COVID-19.

19 https://www.clinicaltrials.gov/ct2/show/NCT04843761?term=TESICO&draw=2&rank=1

The ACTIV3c study is testing the optimal timing and number of mRNA vaccinations for patients recovering from a COVID-19 infection.

22 https://www.clinicaltrials.gov/ct2/show/NCT04969250?term=VATICO&draw=2&rank=1

The ACTIV4B Outpatient study is testing if anticoagulation agents – blood thinners -- prevent mild infection, being treated at home, from worsening and requiring hospitalization.

4 https://clinicaltrials.gov/ct2/show/NCT04498273

The ACTIV4c Post-Discharge study is testing if anticoagulation agents – blood thinners – improve recovery from COVID-19 for individuals after being discharged from the hospital.

8 https://clinicaltrials.gov/ct2/show/NCT04650087

The C3PO study is testing if convalescent plasma -- the liquid portion of blood collected from patients who have recovered from COVID-19 – prevents mild infection, being treated at home, from worsening and requiring hospitalization.

1 https://clinicaltrials.gov/ct2/show/NCT04355767